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 Background: HIV infection is characterized by hormonal and 
immunological changes which may grossly affect the reproductive cycle in 
affected women. Aim: To evaluate Cytokine changes in HIV infected 
women during menstrual cycle. Materials and methods: A total of 90 
women aged between 15 and 45 years were randomly recruited for the study. 
30 of the women were normal healthy seronegative for HIV and served as 
control. Blood samples were collected under sterile conditions during the 
follicular and luteal phases of menstrual cycle after due informed consent 
had been obtained and the samples were analyzed for Cytokines (IL-8, IL-6, 
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IL-4, and TNFα) using Enzyme Linked Immunosorbent Assay (ELISA) 
method. Results: The Cytokines (IL-8, IL-6, IL-4 and TNFα) were 
significantly higher at both phases of menstrual cycle in HIV infected 
women when compared with the Control (P<0.05). Interpretation and 
Conclusion: The study showed significant cytokine changes with some 
degree of inflammatory reactions in HIV infected women. The implication of 
these changes within reproductive life of the women is discussed.  
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INTRODUCTION 
 The Human Immune deficiency Virus/Acquired Immune Deficiency 
Syndrome (HIV/AIDS) pandemic has become a major public health problem 
worldwide especially in sub-Saharan Africa where more than 80 percent of 
all people living with HIV/AIDS reside (UNAIDS 2004; 2012). Reports 
have shown considerable evidence that the rate at which HIV infection 
progresses in women is different from that in men (Farzadegan et al., 1998, 
UNAIDS 2012; USAID, 2012). In Nigeria, about 3.1 million people are 
living with HIV/AIDS while 58% (1.72 million) are females mostly within 
reproductive age (UNAIDS 2011; UNAIDS 2012). In Nigeria HIV is a 
leading cause of morbidity and mortality among women of reproductive age 
(UNAIDS 2011; NACA 2012).  
 HIV infection is known to depress the immune system because of the 
tropic attraction of the virus to the immune cells. Once the immune cells are 
overwhelmed, the infected host becomes immunocompromised and is then 
prone to lots of opportunistic infections. 
 HIV has been known to impact negatively on women’s reproductive 
health (Ikechebelu et al., 2002; Fallahian and Ilkhani, 2006). The negative 
reproductive impact ranges from menstrual disorders and failure of 
reproductive function. 
 Cytokines are low molecular weight extracellular signaling proteins 
secreted by immune inflammatory cell populations (Desair, 2007). They 
have been closely associated with ovarian function in females and are 
believed to be produced locally in the ovulatory follicle where they assist 
granulose cell growth and it inhibits their differentiation. They are also 
believed to stimulate the secretion of ovulation associated substances such as 
prostaglandins which aid in the ovulatory process (Brannstrom et al., 1995). 
Cytokines are believed to play a role in menstruation and implantation since 
they contribute to the defense of the endometrial mucosal epithelium. 
 Since HIV infection affects all body system including the 
reproductive system, cytokine changes occur and this may have some 
undesirable effects on the female reproductive potential.                   
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    The present study was therefore designed to evaluate the cytokine changes 
which are associated with the menstrual cycle in HIV infected females of 
reproductive age group in Nnewi, South- East, Nigeria.   
 
MATERIALS AND METHODS 
 The sample population consisted of ninety premenopausal female 
participants within the age range (15-45years). Thirty participants were 
apparently healthy controls recruited amongst the Hospital staff. Thirty 
participants were HIV seropositive females who have not been placed on 
antiretroviral therapy while the remaining thirty were HIV seropositive 
female participants who have been placed on antiretroviral therapy for not 
less than six months. They were recruited at the HIV clinic of Nnamdi 
Azikiwe University Teaching Hospital Nnewi, Anambra State Nigeria. 
 After obtaining informed consent of the participants, a well detailed 
questionnaire was administered to each participant to ascertain their medical 
and reproductive history. Eight milliliters of venous blood was collected 
aseptically between 9.00am and 12noon from each participant at follicular 
(7-13th day) and luteal (21-23rd day) phases of menstrual cycle. All the 
participants were double screened for malaria parasite and HIV infection 
using rapid antigen diagnostic techniques for malaria falciparum and 
immunoassay and immunochromatographic methods for HIV screening 
respectively. The serum content was separated immediately after clot 
retraction, labeled and stored at -20oC for determination  of IL-8, IL-6, IL-4 
and TNFα using ELISA (Enzyme Linked Immunosorbent Assay) method.  
 The ethics committee of NAUTH Nnewi approved the study design 
and only those who gave their consent were recruited for the study.  
 Inclusion and Exclusion criteria: only the participant adjudged as 
HIV stage 2 were recruited for the study. HIV stage 1, stage 3 and stage 4 
were excluded, participant with malaria parasite infection as at the time of 
study were excluded, participants on contraceptives were excluded, women 
with previous history of infertility prior to the study and participants who 
were co-infected with tuberculosis were also excluded from the study. Hence 
the female participants used were those with no prior fertility problems until 
the existence of HIV infection. 
 
Methods 
 Antibodies to HIV-1 and HIV-2 in Human Plasma were detected 
using Abbott Deterimine system, Immunoassay method [(Trinity Biotech 
UniGold Assay Kit (Trinity Biotech PLC, Ireland)] and 
imunochromatographic method [(HIV 1 and 2 STAT-PAK Assay kit 
(Chembio diagnostic system, INC New York, USA)] respectively. 
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 Determination of TNF-α, Interleukin-4, 6 and 8 were done using 




 The version 16 of SPSS package was used in statistical analysis. The 
variables were expressed as mean (±SD). The student t-test and analysis of 
variance (ANOVA) and post-hoc (LSD) were used to assess significant mean 
differences. Graph Pad Prism version 5.03 was used for graph presentations. 
 
RESULTS 
Levels of Cytokines (IL-8) at Follicular and Luteal Phases of Menstrual 
cycle 
 The mean (±SD) plasma IL-8 concentration (pg/ml) dropped 
significantly at luteal phase (742.5±197.7, 377.1±174.2) compared with 
follicular phase (876.4±387.2, 550.9±183.6) of menstrual cycle in HIV 
seropositive females and HIV seropositive females on ART (P<0.05 
respectively). When the mean IL-8 value (pg/ml) at follicular and luteal 
phases of menstrual were compared between the Control group and Test 
groups, the mean IL-8 was significantly higher in HIV seropositive females 
(876.4±387.2, 742.5±197.7) and HIV seropositive females on ART 
(550.9±183.6, 377.1±174.2) compared with follicular and luteal values in the 
Control female subjects (280.1±47.7, 276.9±56.3) (P<0.05 respectively).  
 The post hoc analysis showed significant drop in the mean IL-8 value 
(pg/ml) at follicular and luteal phases of menstrual cycle in HIV seropositive 
females on ART (550.9±183.6, 377.1±174.2) compared with follicular and 
luteal values in the HIV seropositive females (876.4±387.2, 742.5±197.7) 
(P<0.05 respectively) (See fig 1). 
 
Levels of Cytokines (IL-6) at Follicular and Luteal Phases of Menstrual 
cycle 
 The mean (±SD) plasma IL-6 concentration (pg/ml) dropped 
significantly at follicular phase (474.1±153.2) of menstrual cycle compared 
with the luteal phase (584.3±271.3) in HIV seropositive female subjects 
(P<0.05). On the other hand, there was no significant difference in the mean 
IL-6 value (pg/ml) between follicular (224.9±54.6) and luteal (296.6±143.7) 
phases of menstrual cycle in HIV seropositive females on ART (P>0.05). 
Similarly, there was no significant difference in the mean IL-6 value between 
follicular (217.6±64.9) and luteal (204.6±36.7) phases of menstrual cycle in 
Control female subjects (P>0.05).  
 When the mean IL-6 concentration (pg/ml) at follicular  and luteal 
phases of menstrual cycle were compared between the Control group and 
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Test groups, the mean IL-6 was higher in HIV seropositive females 
(474.1±153.2, 584.3±271.3) compared with follicular and luteal  values in 
the Control female subjects (217.6±64.9, 204.6±36.7) (P<0.05respectively).  
 The post hoc analysis showed significant drop in the mean IL-6 value 
(pg/ml) at follicular and luteal phases of menstrual cycle in HIV seropositive 
females on ART (224.9±54.6, 296.6±143.7) compared with follicular and 
luteal values in the HIV seropositive females (474.1±153.2, 584.3±271.3) 
(P<0.05 respectively) (See fig 2) 
 
Levels of Cytokines (IL-4) at Follicular and Luteal Phases of Menstrual 
cycle 
 The mean (±SD) plasma IL-4 concentration (pg/ml) in HIV 
seropositive females significantly dropped at luteal (354.9±207.7) compared 
with follicular (497.6±216.1) phase of menstrual cycle (P<0.05). But the 
mean IL-4 value (pg/ml) dropped significantly at follicular (527.2±231.3) 
compared with luteal phases (660.2±254.2) in HIV seropositive females on 
ART (P<0.05).  The mean IL-4 value (pg/ml) dropped significantly at 
follicular phase (210.7±71.2) compared with luteal phase (334.8±76.5) in 
Control female subjects (P<0.05).  
 When the mean IL-4 concentration (pg/ml) at follicular and luteal 
phases were compared between the Control group and Test groups, the mean 
IL-4 was significantly higher in HIV seropositive females (354.9±207.7, 
497.6±216.1) and HIV seropositive females on ART (527.2±231.3, 
660.2±254.2) compared with follicular and luteal values in the Control 
female subjects (210.70±71.2, 334.8±76.5) (P<0.05 in each case).  
 The post hoc analysis showed significantly higher mean IL-4 value 
(pg/ml) at follicular and luteal phases of menstrual cycle in HIV seropositive 
females on ART (527.2±231.3, 660.2±254.2) compared with follicular value 
in HIV seropositive females (354.9±207.7, 497.6±216.1) (P<0.05 
respectively) (See fig 3).  
 
Levels of Cytokines (TNFα) at Follicular and Luteal Phases of 
Menstrual cycle 
 The mean (±SD) plasma TNFα concentration (pg/ml) dropped 
significantly at luteal phase (788.2±191.7) compared with follicular phase 
(949.6±335.7) of menstrual cycle in HIV seropositive female subjects 
(P<0.05). There was no significant difference in the mean TNFα value 
(pg/ml) between follicular (483.6±160.0) and luteal (519.2±177.8) phases of 
menstrual cycle in HIV seropositive females on ART (P>0.05). The mean 
TNFα value (pg/ml) dropped significantly at follicular phase (211.8±57.6) 
compared to luteal phase (333.0±72.2) of menstrual cycle in Control female 
subjects (P<0.05).  
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 When the mean TNFα concentration (pg/ml) at follicular and luteal 
phases of menstrual cycle were compared between the Control group and 
Test groups, the mean TNFα was significantly higher in HIV seropositive 
females (949.6±335.7, 788.2±191.7) and HIV seropositive females on ART 
(483.8±160.0, 519.2±177.8) compared with follicular and luteal values in the 
Control female subjects (211.8±57.6, 333.0±72.2) (P<0.05 in each case).  
 The post hoc analysis showed significant drop in the mean TNFα 
concentration (pg/ml) at follicular and luteal phases of menstrual cycle in 
HIV seropositive females on ART (483.8±160.0, 519.2±177.8) compared 
with follicular and luteal values in HIV seropositive female subjects 















 The study showed significantly higher levels of IL-8 and TNFα in 
HIV seropositive females and HIV seropositive females on ART at follicular 
phase compared to luteal phase of menstrual cycle. Cytokines including 
TNFα and IL-8 are secreted by activated monocytes. It is worthy to note that 
monocytes populations are reduced in diseased states such as HIV infection 
indicating reduced cellular immunity which is one of the problems in these 
subjects. The increased secretion of these cytokines therefore may be due to 
hyperstimulation of the surviving monocytic cells. It has been reported that 
endotoxin stimulated monocytes of women in the luteal phase produced 
more TNFα when compared to follicular phase (Brannstrom et al., 1999; 
Bouman et al., 2001). IL-8 was also found to be significantly elevated at the 
follicular phase compared with the luteal phase (Al- Harthi, 2001) which 
implied increased inflammatory response and enhanced cellular immunity in 
this phase and this may have been induced by reduced progesterone and 
estrogen production. This report is consistent with the observation in the 
present study. 
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 The significantly higher level of TNFα in HIV seropositive female 
subjects at the follicular phase when compared with the luteal phase is 
inconsistent with findings in healthy women. It has been documented that in 
apparently healthy women, TNFα is generally higher at the luteal phase 
during which the population of activated monocytes, which secret TNFα, are 
reported to be higher (Marthur et al., 1979; Northern et al., 1994; 
Brannstrom et al., 1999). This is probably due to the fact that the luteal phase 
is the time when fertilization takes place and the fertilized ovum requires 
protection from infective agents hence the increased pro- inflammatory 
activity (Norman, 2001). 
 The significantly higher level of IL-6 at the luteal phase compared 
with the follicular phase in the present study is comparable with the previous 
reports done in developed countries (Konecna et al., 2000). IL-6 is said to 
stimulate B-lymphocytes (thereby enhancing humoral immunity) and T- 
lymphocytes differentiation and activate macrophages and NK- cells 
(thereby enhancing cellular immunity). It is also said to possess 
antinflammatory properties (Marijke et al., 2011). Since IL-6 production is 
said to be decreased by estrogen, the low estrogen production associated with 
hypogonadism in HIV subjects result in increased IL-6 production since sex 
hormones perform immunoregulatory functions. 
 Reports of IL-6 levels during the menstrual cycle phases have been 
controversial. Whereas Angstwurm et al., (1997) reported higher levels of 
IL-6 during the follicular phase of menstrual cycle, Abrahamsen et al., 
(2003) reported no difference while Schwarz et al., (2000) reported 
decreased IL-6 in the follicular phase during the menstrual cycle. It has been 
reported that during the luteal phase of menstrual cycle, the immune 
response is shifted toward a Th2-type response and this was found to 
correspond to increased levels of progesterone and 17β-E2 (Marijke et al., 
2000). This account for the anti-inflammatory immune response associated 
with IL-6 production at this phase and reduced cellular immunity. 
 The significantly high levels of IL-8, IL-6, IL-4 and TNFα in HIV 
seropositive females and HIV seropositive females on ART compared to 
Control females at both follicular and luteal phases of menstrual cycle also 
showed higher degree of inflammation in diseased subjects when compared 
to healthy people. Excessive production of some cytokines for instance 
TNFα has been associated with problems such as fever or even tumor 
formation hence certain neoplastic conditions such as Karposi sarcomas are 
said to be common in chronic HIV patients (Locksley et al., 2001). The 
increased IL-4 may be due to antiiflammatory effects of estrogen thereby 
promoting Th2 immune response. Moreover, HIV is a chronic inflammatory 
disease and is said to induce a Th-1type immune responses which are 
characterized by the production of pro-inflammatory cytokines some of 
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which have been associated with harmful effects such as fever and tumors 
formation (Chowdbury et al., 2010). The implications of elevated cytokines 
on endocrine and metabolic functions have been previously reported 
(Hashimoto et al., 1994; Gartner, 2009) and this has far reaching effects on 
menstrual and reproductive functions of the affected women (O’ Brien et al., 
2007).  
 However, the significantly reduced levels of IL-8, IL-6, IL-4 and 
TNFα in HIV seropositive females on ART compared to their counterparts 
without treatment showed significant reduction of inflammation and perhaps 
some level of improvement in the reproductive function in these subjects due 
to a reduction in viral load (AL-Harthi et al., 2001). This signifies beneficial 
effects of treatment which results in significant restoration of the cellular 
immunity and reduction of inflammation in these patients. This has been 
previously reported (Sachdeva et al., 2010).The fluctuations in the levels of 
cytokines have been reported to be related to hypogonadal function as has 
been discussed previously (Marijke et al., 2000).  
 The significantly increased levels of the anti inflammatory cytokine 
(IL-4) in HIV seropositive females on ART especially at the luteal phase 
were consistent with the value observed in Control females. These signify a 
reduction or modulation of inflammatory activities and humoral immunity 
which is a Th2 type of response. IL-4 is also secreted by activated immune 
cells such as monocytes. It has been reported that variations in progesterone 
and estrogen (sex hormones) induced by HIV infections drive the immune 
response to either a Th1 type or Th2 type response depending on the 
concentration of these hormones. This leads to the exaggeration of either 
pro-inflammatory cytokines such as TNFα or anti-inflammatory cytokines 
such as IL-4 (Marijke et al., 2000). It has also been reported that cytokines 
are elevated in systemic diseases and this can directly inhibit the ovary in 
females (Marijke et al., 2000).  
 The present study therefore, concludes that there were cytokine 
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